Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients.

Antimicrobial Agents and Chemotherapy
J D NelsonS Shelton

Abstract

Two dosages of a liquid suspension formulation of amoxicillin and potassium clavulanate were tested in 34 infants and children. The smaller dosage resulted in suboptimal plasma concentrations. With a greater dosage (3.3 mg of clavulanate per kg and 13.3 mg of amoxicillin per kg), the mean peak plasma concentrations were 1.6 micrograms clavulanic acid per ml and 4.9 micrograms amoxicillin per ml.

References

Jul 1, 1980·The Journal of Antimicrobial Chemotherapy·P A HunterD Taylor

❮ Previous
Next ❯

Citations

Oct 1, 1996·The Pediatric Infectious Disease Journal·M D Reed
Jan 7, 1999·The Pediatric Infectious Disease Journal·S M Abdel-Rahman, G L Kearns
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·U B SchaadD L Cooper
Nov 1, 1983·Antimicrobial Agents and Chemotherapy·G R FleisherJ M Campos
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·F F HorberF C Reubi
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·G H KeelerJ J Rash
Oct 20, 2005·Clinical Pharmacokinetics·Amparo Sánchez Navarro
Jan 1, 1985·European Journal of Clinical Pharmacology·C H van NiekerkE A Louw
Jan 1, 1987·Infection Control : IC·R H Parker, M Eggleston
Jun 1, 1985·Drug Intelligence & Clinical Pharmacy·B R Smith, J L LeFrock
Jan 1, 1986·The Journal of International Medical Research·L Tazi-LakhsassiM Sehlane

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.